Visual Acuity and Quality of Life Outcomes With Pegcetacoplan Treatment: A Post Hoc Analysis From the OAKS and DERBY Trials
Open Access
- 29 May 2025
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 277, 471-481
Abstract
No abstract availableKeywords
Funding Information
- Apellis Pharmaceuticals Inc
This publication has 24 references indexed in Scilit:
- Disease Activity and Therapeutic Response to Pegcetacoplan for Geographic Atrophy Identified by Deep Learning-Based Analysis of OCTOphthalmology, 2024
- Drug Approval for the Treatment of Geographic Atrophy: How We Got Here and Where We Need to GoAmerican Journal of Ophthalmology, 2024
- The Effect of Pegcetacoplan Treatment on Photoreceptor Maintenance in Geographic Atrophy Monitored by Artificial Intelligence–Based OCT AnalysisOphthalmology Retina, 2022
- Relationship of Topographic Distribution of Geographic Atrophy to Visual Acuity in Nonexudative Age-Related Macular DegenerationOphthalmology Retina, 2021
- Visual Function Decline Resulting from Geographic AtrophyOphthalmology Retina, 2020
- The Progression of Geographic Atrophy Secondary to Age-Related Macular DegenerationOphthalmology, 2018
- Geographic Atrophy and Foveal-Sparing Changes Related to Visual Acuity in Patients With Dry Age-Related Macular Degeneration Over TimeAmerican Journal of Ophthalmology, 2017
- Natural History of Geographic Atrophy Progression Secondary to Age-Related Macular Degeneration (Geographic Atrophy Progression Study)Ophthalmology, 2016
- Characteristics of Incident Geographic Atrophy in the Complications of Age-Related Macular Degeneration Prevention TrialOphthalmology, 2013
- Visual Acuity as an Outcome Measure in Clinical Trials of Retinal DiseasesOphthalmology, 2007